The specific peptides identified are bioactive sequences derived from milk proteins that address the deficiency of natural immunomodulatory factors in infants or immunocompromised subjects. Solving this provides a technical advantage by enhancing systemic pathogen defense and gut-associated lymphoid tissue maturation.